"Pre-Eclampsia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
| Descriptor ID |
D011225
|
| MeSH Number(s) |
C13.703.395.249
|
| Concept/Terms |
Pre-Eclampsia- Pre-Eclampsia
- Pre Eclampsia
- Preeclampsia
- Pregnancy Toxemias
- Pregnancy Toxemia
- Toxemia, Pregnancy
- Edema-Proteinuria-Hypertension Gestosis
- Edema Proteinuria Hypertension Gestosis
- Gestosis, Edema-Proteinuria-Hypertension
- Hypertension-Edema-Proteinuria Gestosis
- Gestosis, Hypertension-Edema-Proteinuria
- Hypertension Edema Proteinuria Gestosis
- Toxemia Of Pregnancy
- Of Pregnancies, Toxemia
- Of Pregnancy, Toxemia
- Pregnancies, Toxemia Of
- Pregnancy, Toxemia Of
- Toxemia Of Pregnancies
- EPH Complex
- EPH Toxemias
- EPH Toxemia
- Toxemia, EPH
- Toxemias, EPH
- EPH Gestosis
- Gestosis, EPH
- Toxemias, Pregnancy
- Preeclampsia Eclampsia 1
- 1, Preeclampsia Eclampsia
- 1s, Preeclampsia Eclampsia
- Eclampsia 1, Preeclampsia
- Eclampsia 1s, Preeclampsia
- Preeclampsia Eclampsia 1s
- Proteinuria-Edema-Hypertension Gestosis
- Gestosis, Proteinuria-Edema-Hypertension
- Proteinuria Edema Hypertension Gestosis
|
Below are MeSH descriptors whose meaning is more general than "Pre-Eclampsia".
Below are MeSH descriptors whose meaning is more specific than "Pre-Eclampsia".
This graph shows the total number of publications written about "Pre-Eclampsia" by people in this website by year, and whether "Pre-Eclampsia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 1 | 0 | 1 |
| 1998 | 6 | 1 | 7 |
| 1999 | 0 | 1 | 1 |
| 2000 | 3 | 1 | 4 |
| 2001 | 3 | 1 | 4 |
| 2002 | 2 | 0 | 2 |
| 2003 | 4 | 0 | 4 |
| 2004 | 3 | 1 | 4 |
| 2005 | 2 | 0 | 2 |
| 2006 | 5 | 0 | 5 |
| 2007 | 9 | 1 | 10 |
| 2008 | 5 | 0 | 5 |
| 2009 | 4 | 1 | 5 |
| 2010 | 6 | 0 | 6 |
| 2011 | 5 | 3 | 8 |
| 2012 | 8 | 1 | 9 |
| 2013 | 7 | 1 | 8 |
| 2014 | 3 | 1 | 4 |
| 2015 | 5 | 1 | 6 |
| 2016 | 5 | 0 | 5 |
| 2017 | 3 | 2 | 5 |
| 2018 | 5 | 1 | 6 |
| 2019 | 5 | 0 | 5 |
| 2020 | 5 | 2 | 7 |
| 2021 | 10 | 1 | 11 |
| 2022 | 12 | 0 | 12 |
| 2023 | 11 | 0 | 11 |
| 2024 | 5 | 2 | 7 |
| 2025 | 7 | 1 | 8 |
| 2026 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pre-Eclampsia" by people in Profiles.
-
Neonatal outcome gains from sFlt-1/PlGF testing in hypertensive disorders of pregnancy: Modeled estimates from real-world data in the US. Pregnancy Hypertens. 2026 Sep; 45:101507.
-
Reply to the letter to the editor: "Machine learning model for predicting preeclampsia-related adverse outcomes". Pregnancy Hypertens. 2026 09; 45:101501.
-
Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia. Placenta. 2026 Aug; 182:150-157.
-
Internal and external validation of a machine learning algorithm to detect preeclampsia-related adverse outcomes in high-risk pregnancies. Pregnancy Hypertens. 2026 Jun; 44:101457.
-
Preeclampsia and Risk of Apnea of Prematurity in Late Preterm Infants: A Retrospective Cohort Study. Pediatr Pulmonol. 2026 Feb; 61(2):e71485.
-
Serum soluble-fms-like tyrosine kinase 1-to-placental growth factor ratio on Elecsys immunoassay platform predicts preeclampsia with severe features in hospitalized women with hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2026 Mar; 234(3):834-855.
-
Plasma markers of neurological injury are elevated in preeclampsia. Pregnancy Hypertens. 2025 Dec; 42:101265.
-
Impact of PlGF immunoassay imprecision on preeclampsia risk assessment with the sFlt-1 to PlGF ratio. Am J Clin Pathol. 2025 08 26; 164(2):200-206.
-
Reference Range Determination for the sFlt-1/PlGF Ratio in a Diverse Cohort of Pregnant Women in the United States. J Appl Lab Med. 2025 07 01; 10(4):937-948.
-
Placental Biomarker Testing for Evaluation of Suspected Preeclampsia. Clin Chem. 2025 May 02; 71(5):548-558.